BioPortoDx Profile Banner
BioPortoDx Profile
BioPortoDx

@BioPortoDx

Followers
359
Following
371
Media
264
Statuses
348

Providing NGAL tests that help clinicians worldwide confidently assess AKI earlier. The regulatory status of our tests varies by region.

Global
Joined May 2019
Don't wanna be here? Send us removal request.
@BioPortoDx
BioPortoDx
11 days
BioPorto is excited to attend #NeoHeart2025. Stop by table 4 to learn about the #NGAL biomarker to manage #AKI in your patients. See you in San Diego! #NGAL4kids.#NICU #PCICU
Tweet media one
0
0
2
@BioPortoDx
BioPortoDx
16 days
Don’t miss these #ADLM2025 sessions. Learn about renal biomarkers for the early prediction and management of acute kidney injury. Visit booth 5327 to learn about BioPorto’s NGAL tests. #NGAL4AKI #NGAL4kids.@myADLM
Tweet media one
0
1
1
@BioPortoDx
BioPortoDx
24 days
Attending #NeoHeart2025 in San Diego? Let’s talk about NGAL for earlier AKI assessment in your patients. Discover how this biomarker offers an additional data point to inform your care decisions earlier and with confidence. #NGAL4kids #NGAL4AKI
Tweet media one
0
0
1
@BioPortoDx
BioPortoDx
26 days
We are excited to be part of #ADLM2025. Visit us at booth 5327 for an update on ProNephro AKI and our adult clinical study. Learn more about NGAL testing for earlier AKI risk assessment. See you in Chicago!
Tweet media one
0
0
1
@BioPortoDx
BioPortoDx
2 months
#ESPNIC2025 is just a few days away. Be sure to join our symposium for lunch and learn about NGAL for managing fluids in your critically ill patients at risk of AKI. Connect with @csc_wodarz in a session or visit us at stand 23 in the exhibit hall. @ESPNIC_Society #NGAL4kids
Tweet media one
0
1
4
@BioPortoDx
BioPortoDx
2 months
Don’t miss Prof. Shacham’s poster presentation at #43VicenzaCourse where he will share how NGAL can aid in early risk stratification for STEMI patients at risk of AKD. This is a great opportunity to learn how NGAL can help improve patient outcomes. #KidneyHealthForAll #AKD
Tweet media one
0
1
2
@BioPortoDx
BioPortoDx
2 months
The BioPorto team will be in Alicante and available to meet at #ESPNIC2025. Reach out to put a meeting on the calendar, stop by stand 23 to say hello, or join our lunch symposium to learn how NGAL can help you improve AKI and fluid management.👇.@ESPNIC_Society
Tweet media one
0
1
4
@BioPortoDx
BioPortoDx
2 months
Headed to #ESPNIC2025? Don’t miss our June 26th lunch symposium. Learn how the NGAL biomarker can help you manage fluids and AKI in your critically ill patients, including the latest research on the use of NGAL for RRT liberation. #NICU #PICU #NGAL4kids.@ESPNIC_Society
Tweet media one
0
1
4
@BioPortoDx
BioPortoDx
3 months
BioPorto's Ray White is attending #NTI2025. Connect with him to learn how NGAL testing can help you be a kidney hero – identify and manage #AKI earlier to reduce or prevent kidney damage. #NGAL4kids.
@AACNme
American Association of Critical-Care Nurses
3 months
Headed to NTI 2025 in New Orleans? We want to see it all—your sessions, your squad, your coffee runs, your second line moves! Tag your posts with #NTI2025 for a chance to be featured on AACN’s social media!
Tweet media one
0
2
5
@BioPortoDx
BioPortoDx
3 months
Today, we celebrate #ICU teams worldwide for their collaboration to drive technological and therapeutic advances while delivering compassionate, quality, patient-centered, and personalized care. #CritCareMonth #BlueICU.@ICU_Management.@SCCM @CritCareMed @ESPNIC_Society
Tweet media one
0
1
2
@BioPortoDx
BioPortoDx
3 months
Knowledge of #AKI risks can help care teams manage their patients and help avoid poor outcomes. @Newsweek.
Tweet card summary image
newsweek.com
Cardiac surgery brings in millions of dollars for health systems—but a common, costly complication is quietly eating at the profits.
0
0
1
@BioPortoDx
BioPortoDx
3 months
RT @Ped_Neph: AKI commonly occurs in critically ill children, but its impact on pediatric growth outcomes has been sparsely described. Read….
0
7
0
@BioPortoDx
BioPortoDx
3 months
👏🎉Today, we celebrate World PICU Awareness Day by recognizing the PICU teams worldwide for their relentless efforts in driving impactful and innovative solutions for continued improvement in pediatric critical care. #CritCareMonth #WPAW25 #PedsICU. @WFPICCS @ESPNIC
Tweet media one
0
2
5
@BioPortoDx
BioPortoDx
3 months
The critical care community has lost a great innovator and leader in AKI and biomarkers. He will be missed by many.
@VicenzaCourse
VicenzaCourse
3 months
Vicenza team is deeply saddened by the passing of Prof Bellomo. His strong connection and support for #VicenzaCourse were instrumental in its growth and reputation. We remember him with heartfelt gratitude. His legacy will continue to live on in all those he taught and inspired
Tweet media one
0
1
4
@BioPortoDx
BioPortoDx
3 months
Learn from pediatric intensivists worldwide how innovation, teamwork, and smarter technology are reshaping care in #PedsICU. We celebrate our collaborations with global #PICU teams every day – thank you for all you do to advance care and improve outcomes in your patients.
@WFPICCS
WFPICCS
3 months
🌍 World PICU Awareness Week 2025 starts TOMORROW!. 🎯 This year’s theme: Tech & Innovation in PICU.📢 Daily podcast series.🌐 Global campaign.📅 First episode drops tomorrow!.🔗 Calendar: #WPAW25 #PedsICU
Tweet media one
0
1
2
@BioPortoDx
BioPortoDx
3 months
We are excited to see #AKI on the program at EuroMedLab 2025. Don’t miss sessions by @ClinChemJoe and @MarliesOst. While you’re there, connect with @JenZ4NGAL to learn more about BioPorto’s NGAL tests for earlier AKI identification and management, and our ongoing adult clinical
Tweet media one
3
0
2
@BioPortoDx
BioPortoDx
4 months
Join the ISCCN community for research, education, and professional development dedicated to critical care nephrology. 📸.@ForniLuiG – founder & board member.Mitra Nadim, MD – early joiner. Join today at
Tweet media one
0
0
1
@BioPortoDx
BioPortoDx
4 months
AKI in pediatric solid organ transplant patients is common, affecting 37-57%, depending on the type of transplanted organ. Ask us how BioPorto’s NGAL tests can help you assess #AKI risk in these vulnerable patients. #KidsTransplantWeek #NGAL4kids
Tweet media one
0
1
2
@BioPortoDx
BioPortoDx
4 months
This #LabWeek, we celebrate all labs working hard to save patients’ lives, from our lab team in Denmark creating our NGAL products to our customer labs using NGAL to identify and manage acute kidney injury. #ASCPLabWeek25 #LabsSaveLives #GlobalMedLabWeek @_EFLM
Tweet media one
0
1
2